Trademark Search  /  SINGULERA

SINGULERA

● Live · Pending

U.S. federal trademark · Serial No. 50145475

Mark
SINGULERA
Status
Pending
Serial Number
50145475
Filing Date
September 24, 2026
Class(es)
Class 005, Class 040, Class 042, Class 044

Owner

Singulera Therapeutics Inc.
03 · Chicago, IL, US

Goods & Services

Custom manufacturing of pharmaceuticals; Custom manufacturing of biological tissue, blood, cell and genetic material; Custom manufacturing of biological preparations; Custom biomanufacturing of pharmaceutical preparations; Custom biomanufacturing of pharmaceuticals containing cultured cells for use in cell therapy; Custom manufacturing of cell therapy preparations; Contract biomanufacturing in the field of pharmaceuticals

Syringes sold filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes sold filled with pharmaceuticals for chronic wound healing, including non-healing ulcers; Syringes sold filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes sold filled with pharmaceuticals for cardiovascular diseases, including acute myocardial infarction and ischemic conditions; Syringes sold filled with regenerative pharmaceuticals for skin and tissue repair; Organotherapy preparations; Biological preparations for use in cell cultures for medical purposes; Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Pharmaceutical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; Pharmaceutical preparations for cell therapy for medical purposes; Pharmaceutical preparations for gene therapy for medical purposes; Pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; Pharmaceutical preparations for therapies to modulate the immune system; Pharmaceutical preparations for therapeutic delivery of nucleic acids; Medical pharmaceutical preparations containing viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Stem cells for medical purposes; Opotherapy preparations; Biological reagent for medical purposes; Immunostimulants

Biological research; Biotechnological research; Medical research; Research and development of new products for others; Technological research in the field of biotechnology; Conducting technical project studies; Industrial research in the field of biotechnology; Research and development of pharmaceutical preparations; Conducting clinical trials for others; Research and development in the field of cell therapy; Research and development in the field of biopharmaceuticals; Research and development of pharmaceutical manufacturing processes; Research and development of biopharmaceutical manufacturing processes; Testing and analysis of pharmaceutical products

Medical services; Medical and pharmaceutical consultation; Providing medical information; Stem cell therapy services; Immunotherapy services; Medical treatment services for autoimmune diseases; Medical services for the prevention and treatment of organ transplant rejection

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "SINGULERA" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.